Assistant Director of Bioinformatics
Personalized Medicine, Mass General Brigham
Principal Investigator
Dr. Koyama studies how human genetic variation contributes to disease risk, molecular mechanisms, and precision prevention across a broad range of human diseases, with a particular focus on cardiometabolic traits. His training in cardiovascular medicine, human genetics, and computational biology grounds the lab's work in rigorous statistical genetics and patient-centered translation.
Personalized Medicine, Mass General Brigham
Heart and Vascular Institute, Mass General Brigham
Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard
Harvard Medical School
Kyoto University
Kobe University
Broad Institute of MIT and Harvard
RIKEN
Hyogo Prefectural Amagasaki Hospital
Kobe City General Hospital
NIH/NHLBI Pathway to Independence Award (R00), R00HL169733 / PI
Extends the genetic understanding of familial hypercholesterolemia and coronary artery disease through whole-genome sequence interpretation.
NIH/NHLBI Pathway to Independence Award (K99), K99HL169733 / PI
Characterized rare coding and non-coding variants in familial hypercholesterolemia and developed integrated risk prediction approaches.
The Uehara Memorial Foundation / PI
Defined how rare variants shape coronary artery disease risk, with a focus on blood lipid traits.
JSPS Overseas Research Fellowship, 202160643 / PI
Identified rare effector variants for coronary artery disease using whole-genome sequencing datasets.
JSPS Research Fellowship for Young Scientists (DC1), 15J00784 / PI
Described blood microRNA dynamics during acute decompensation in heart failure.
University of Kentucky Gill Heart & Vascular Institute
Recognized contributions to genetic analysis in atherosclerotic cardiovascular disease.
CARDIoGRAMplusC4D Consortium
American Heart Association Council on Genomic and Precision Medicine